NDC 65219-082

Gadoterate Meglumine

Gadoterate Meglumine

Gadoterate Meglumine is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Gadoterate Meglumine.

Product ID65219-082_afd3cf46-3d9c-4d0e-a02a-42cf846ba1e7
NDC65219-082
Product TypeHuman Prescription Drug
Proprietary NameGadoterate Meglumine
Generic NameGadoterate Meglumine
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-06-20
Marketing CategoryANDA /
Application NumberANDA215304
Labeler NameFresenius Kabi USA, LLC
Substance NameGADOTERATE MEGLUMINE
Active Ingredient Strength377 mg/mL
Pharm ClassesGadolinium-based Contrast Agent [EPC], Magnetic Resonance Contrast Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 65219-082-10

10 CARTON in 1 BOX (65219-082-10) > 1 VIAL in 1 CARTON (65219-082-01) > 10 mL in 1 VIAL
Marketing Start Date2022-06-20
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Gadoterate Meglumine" or generic name "Gadoterate Meglumine"

NDCBrand NameGeneric Name
65219-080Gadoterate Megluminegadoterate meglumine
65219-082Gadoterate Megluminegadoterate meglumine
65219-084Gadoterate Megluminegadoterate meglumine
65219-086Gadoterate Megluminegadoterate meglumine
65219-088Gadoterate Megluminegadoterate meglumine
0407-2943CLARISCANgadoterate meglumine
67684-2000DOTAREMgadoterate meglumine
67684-2001DOTAREMgadoterate meglumine
67684-3001DOTAREMgadoterate meglumine

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.